Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Byington

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Hypertension|March 1, 1993
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis StudyC D Furberg, N O Borhani, R P Byington, et al.
Diabetes Care|May 8, 1998
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDMP Tatti, M Pahor, R P Byington, et al.
Journal of the American College of Cardiology|January 1, 1986
Effect of propranolol in patients with myocardial infarction and ventricular arrhythmiaL M Friedman, R P Byington, R J Capone, et al.
Circulation|September 27, 2000
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsB Pitt, R P Byington, C D Furberg, et al.
Circulation|February 7, 2001
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) ProjectR P Byington, B R Davis, J F Plehn, et al.
Controlled Clinical Trials|February 1, 1996
Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterolT A Dolecek, K H Bradham, M A Espeland, et al.
Circulation|July 21, 1999
Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research GroupR P Byington, G W Evans, M A Espeland, et al.
Controlled Clinical Trials|December 1, 1992
Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcomeJ R Crouse, R P Byington, M G Bond, et al.
The American Journal of Cardiology|November 14, 1997
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)R P Byington, M E Miller, D Herrington, et al.
Circulation|March 1, 1993
Methodological issues facing studies of atherosclerotic changeJ L Probstfield, R P Byington, D A Egan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Hypertension|March 1, 1993
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis StudyC D Furberg, N O Borhani, R P Byington, et al.
Diabetes Care|May 8, 1998
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDMP Tatti, M Pahor, R P Byington, et al.
Journal of the American College of Cardiology|January 1, 1986
Effect of propranolol in patients with myocardial infarction and ventricular arrhythmiaL M Friedman, R P Byington, R J Capone, et al.
Circulation|September 27, 2000
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsB Pitt, R P Byington, C D Furberg, et al.
Circulation|February 7, 2001
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) ProjectR P Byington, B R Davis, J F Plehn, et al.
Controlled Clinical Trials|February 1, 1996
Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterolT A Dolecek, K H Bradham, M A Espeland, et al.
Circulation|July 21, 1999
Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research GroupR P Byington, G W Evans, M A Espeland, et al.
Controlled Clinical Trials|December 1, 1992
Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcomeJ R Crouse, R P Byington, M G Bond, et al.
The American Journal of Cardiology|November 14, 1997
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)R P Byington, M E Miller, D Herrington, et al.
Circulation|March 1, 1993
Methodological issues facing studies of atherosclerotic changeJ L Probstfield, R P Byington, D A Egan, et al.
Pageof 4